Приказ основних података о документу

dc.creatorSavić, Miroslav
dc.creatorClayton, Terry
dc.creatorFurtmueller, Roman
dc.creatorGaurilović, Ivana
dc.creatorSamardžić, Janko
dc.creatorSavić, Snežana
dc.creatorHuck, Sigismund
dc.creatorSieghart, Werner
dc.creatorCook, James M.
dc.date.accessioned2019-09-02T11:13:41Z
dc.date.available2019-09-02T11:13:41Z
dc.date.issued2008
dc.identifier.issn0006-8993
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/1081
dc.description.abstractBenzodiazepine (BZ) site ligands affect vigilance, anxiety, memory processes, muscle tone and epileptogenic propensity through modulation of neurotransmission at GABA(A) receptors containing alpha 1, alpha 2, alpha 3 or alpha 5 subunits, and may have numerous experimental and clinical applications. The ability of non-selective BZ site inverse agonists to enhance cognition, documented in animal models and human studies, is clinically not feasible due to potentially unacceptable psychomotor effects. Most investigations to date have proposed the alpha 1 and/or alpha 5 subunit-containing GABA(A) receptors as comprising the memory-modulating population of these receptors. The novel ligand PWZ-029, which we synthesized and characterized electrophysiologically, possesses in vitro binding selectivity and moderate inverse agonist functional selectivity at alpha 5-containing GABA(A) receptors. This ligand has also been examined in rats in the passive and active avoidance, spontaneous locomotor activity, elevated plus maze and grip strength tests, primarily predictive of the effects on the memory acquisition, basal locomotor activity, anxiety level and muscle tone, respectively. The improvement of task learning was detected at the dose of 5 mg/kg in the passive, but not active avoidance test. The inverse agonist PWZ-029 had no effect on anxiety or muscle tone, whereas at higher doses (10 and 20 mg/kg) it decreased locomotor activity. This effect was antagonized by flumazenil. and also by the lower (but not the higher) dose of an agonist (SH-053-R-CH3-2'F) selective for GABA(A) receptors containing the alpha 5 subunit. The hypolocomotor effect of PWZ-029 was not antagonized by the antagonist beta-CCt exhibiting a preferential affinity for alpha 1-subunit-containing receptors. These data suggest that moderate negative modulation at GABA(A) receptors containing the alpha 5 subunit is a sufficient condition for eliciting enhanced encoding/consolidation of declarative memory, while the influence of higher doses of modulators at these receptors on motor activity shows an intricate pattern whose relevance and mechanism await to be defined.en
dc.publisherElsevier Science BV, Amsterdam
dc.relationNIMH NIH HHS 46851
dc.rightsopenAccess
dc.sourceBrain Research
dc.subjectGABA(A)en
dc.subjectinverse agonisten
dc.subjectmemoryen
dc.subjectlocomotor activityen
dc.subjectsubtype-selectivityen
dc.titlePWZ-029, a compound with moderate inverse agonist functional selectivity at GABA(A) receptors containing alpha 5 subunits, improves passive, but not active, avoidance learning in ratsen
dc.typearticle
dc.rights.licenseARR
dcterms.abstractФуртмуеллер, Роман; Савић, Мирослав; Сиегхарт, Wернер; Хуцк, Сигисмунд; Савић, Снежана; Гауриловић, Ивана; Самарджић, Јанко; Цоок, Јамес М.; Цлаyтон, Террy;
dc.citation.volume1208
dc.citation.spage150
dc.citation.epage159
dc.citation.other1208: 150-159
dc.citation.rankM22
dc.identifier.wos000256937800018
dc.identifier.doi10.1016/j.brainres.2008.02.020
dc.identifier.pmid18394590
dc.identifier.scopus2-s2.0-43049159557
dc.identifier.fulltexthttps://farfar.pharmacy.bg.ac.rs//bitstream/id/63/1079.pdf
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу